rawfin.tv
Kalshi Expands Into Biotech With Drug Trial Prediction Markets
TechnologytechAI Generated

Kalshi Expands Into Biotech With Drug Trial Prediction Markets

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Kalshi Inc. is venturing into the biotechnology industry by introducing prediction markets for clinical trial results. The platform will enable wagers on regulatory decisions and drug development outcomes, mirroring sports-style betting.

Prediction MarketsBiotechnologyHealthcareFinancial InnovationRegulation

Related Articles

Amazon's AI Business Reaches $25 Billion Run Rate

Amazon's AI Business Reaches $25 Billion Run Rate

tech
OpenAI Nears $30 Billion Funding Round at $1.25 Trillion Valuation

OpenAI Nears $30 Billion Funding Round at $1.25 Trillion Valuation

tech
Anthropic S-1 Filing Reveals $80.7 Billion First-Half Loss Ahead of IPO

Anthropic S-1 Filing Reveals $80.7 Billion First-Half Loss Ahead of IPO

tech
Apple Partners with Meta to Run 816-Billion AI Model Locally

Apple Partners with Meta to Run 816-Billion AI Model Locally

tech